SARS CoV-2 seroprevalence among HIV-negative participants using tenofovir/emtricitabine-based PrEP in 2020-a sub-study of PREVENIR-ANRS and SAPRIS-Sero
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined